Financial Analysis Of ZF Company Based On Harvard Analysis Framework

With the change of people's concept of health from "disease,treatment and health" to "health,prevention and health",the vaccine is getting more and more attention.Our country is entering the "aging" and "let go two foetuses" dual compound phase,the elderly and the number of newborn will increase rapidly and immunity is relatively low,the two types of people have more demand on disease prevention,vaccine market has a very broad space for development.ZF has significant influence in China's vaccine industry,and some products are exclusive production and sales in China,so it makes sense to carry out financial analysis.This paper selects the annual report data of ZF company from 2011 to 2016,USES the harvard analytical framework analysis method,and combines the company's financial information and other information to carry out a comprehensive financial analysis.Starting from the strategic analysis and using SWOT comprehensive strategy analysis,it is concluded that ZF is the most suitable strategy to adopt SO strategy,which is to utilize internal advantage resources and seize external development opportunities.The harvard analytical framework provides a relatively comprehensive and effective recommendation and reference value for policy makers from a strategic perspective.In this article,through harvard analysis framework: 1)the strategic analysis point of view: the development strategy of government companies adopt the most appropriate SO it is using its own strong ability of research and development,and the most comprehensive market network marketing system,seize the country to the vaccine industry support policies to develop the ZF company.2)accounting analysis: ZF has large assets,low asset utilization and general asset quality.ZF has a small liability,enhanced bargaining power and enhanced commercial credit.The profitability of the company is strong,the growth is weak,the persistence is not good,the security has the potential risk.3)financial analysis: first of all,ZF's asset operation ability is below the industry average level,and its operation and management level is general.Second,the profitability of ZF assets declined,and the overall profitability was not stable.Once again,ZF has strong short-term solvency and long-term solvency.Meanwhile,ZF has a low debt risk.Finally,ZF's development capacity is below the industry average level,and its development capacity is general.4)forecast: the vaccine sub-industry has a large market potential,large growth space and rich returns.ZF company's future development prospect is better,the market prospect is broader,development momentum foot.In recent years,ZF has been able to gradually expand its distribution in the field of therapeutic biological medicine,with a large market and development space.This paper USES the exponential smoothing model to predict the operating income,total operating costs and operating profit of ZF company in 2018.After analyzing the ZF company through the harvard analytical framework,some Suggestions on the financial and strategic aspects of ZF are put forward.Financial advice.